J Korean Soc Pediatr Endocrinol.  2011 Dec;16(3):189-192. 10.6065/jkspe.2011.16.3.189.

Pamidronate Treatment in 9-Year-Old Boy Diagnosed with Gorham Disease

Affiliations
  • 1Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. chshinpd@snu.ac.kr

Abstract

Gorham disease is a rare disorder characterized by proliferation of vascular channels resulting in destruction and resorption of osseous matrix. There is no standard treatment defined for this disease, and variable therapies such as medical, surgical, and radiation therapy have been used. Antiresorptive medication, such as bisphosphonate, is used in Gorham disease because they suppress the course of osteolysis and angiogenisis. We report a 9-year-old boy with Gorham disease, who was presented with recurrent hemothorax and treated by pamidronate. After treatment, he showed no recurrence of hemothorax for more than 2 years.

Keyword

Osteolysis, essential; Pamidronate; Child

MeSH Terms

Child
Diphosphonates
Hemothorax
Humans
Osteolysis
Osteolysis, Essential
Recurrence
Diphosphonates
Full Text Links
  • JKSPE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr